价格

OR-156

未知生产厂商

生成 AI 研报

专利

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

Peptide vaccines for cancers expressing tumor-associated antigens
US 8383590 B2申请人: ONCOTHERAPY SCIENCE INC优先权: 2009
US
10 件公开
ISOLATED POLYPEPTIDES AND POLYNUCLEOTIDES USEFUL FOR INCREASING NITROGEN USE EFFICIENCY, ABIOTIC STRESS TOLERANCE, YIELD AND BIOMASS IN PLANTS
EP 3616504 A3申请人: EVOGENE LTD优先权: 2008
EP
US
7 件公开
Human recombinant beta-interferon with improved solubility
US 7052687 B2申请人: FRAUNHOFER GES FORSCHUNG优先权: 1997
US
5 件公开
Methods of increasing abiotic stress tolerance and/or biomass in plants and plants generated thereby
US 7910800 B2申请人: EVOGENE LTD优先权: 2006
US
5 件公开
Cell penetrating peptide, conjugate comprising same, and composition comprising conjugate
US 9902945 B2申请人: GEMVAX & KAEL CO LTD优先权: 2012
EP
US
4 件公开
GPR156 VARIANTS AND USES THEREOF
EP 4230648 A3申请人: REGENERON PHARMA优先权: 2016
EP
US
4 件公开
CA125 gene and its use for diagnostic and therapeutic interventions
- US 9556245 B2
  申请人: O'BRIEN TIMOTHY优先权: 2001
  US
  4 件公开
- US 2009035819 A1
  申请人: UNIV ARKANSAS优先权: 2007
  US
INFLUENZA VACCINES
EP 4126026 A1申请人: DIOSYNVAX LTD优先权: 2020
CN
EP
WO
3 件公开
Recombinant alpha-hemolysin polypeptide of Staphylococcus aureus, having a deletion in the stem domain and heterologous sequences inserted
US 8545853 B2申请人: FILEE PATRICE优先权: 2009
EP
US
3 件公开
METHODS AND COMPOSITIONS USING FGF23 FUSION POLYPEPTIDES
EP 3124612 A1申请人: NOVARTIS AG优先权: 2010
CN
EP
2 件公开

药物

OR-156

专利

CA125 gene and its use for diagnostic and therapeutic interventions